NEKTAR THERAPEUTICS (NKTR) › Total LiabilitiesNEKTAR THERAPEUTICS (NKTR) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $430.56M2011: $408.74M2012: $450.77M2013: $524.43M2014: $405.29M2015: $492.21M2016: $480.75M2017: $421.04M2018: $432.60M2019: $571.97M2020: $461.47M2021: $437.68M2022: $343.96M2023: $267.05M2024: $243.11M2025: $190.57M$190.57M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$190.57M-21.6%2024$243.11M-9.0%2023$267.05M-22.4%2022$343.96M-21.4%2021$437.68M-5.2%2020$461.47M-19.3%2019$571.97M+32.2%2018$432.60M+2.7%2017$421.04M-12.4%2016$480.75M-2.3%2015$492.21M+21.4%2014$405.29M-22.7%2013$524.43M+16.3%2012$450.77M+10.3%2011$408.74M-5.1%2010$430.56M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share